Jan 30, 2019

Experimental drug could be new option for type 2 diabetes

Posted by in categories: biotech/medical, neuroscience

An experimental drug may help people with type 2 diabetes curb their blood sugar without causing it to drop to dangerously low levels.

Researchers found that the compound—dubbed TTP399 for now—improved patients’ blood control when it was added to the standard medication metformin for six months.

And it did so without causing hypoglycemia—blood sugar drops that, if severe, can lead to convulsions or loss of consciousness.

Read more

Comments are closed.